Puma Biotechnology (PBYI) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Puma Biotechnology (PBYI) over the last 7 years, with Q3 2025 value amounting to $0.17.
- Puma Biotechnology's EPS (Weighted Average and Diluted) fell 5853.66% to $0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 5957.45%. This contributed to the annual value of $0.47 for FY2024, which is 501.38% up from last year.
- Latest data reveals that Puma Biotechnology reported EPS (Weighted Average and Diluted) of $0.17 as of Q3 2025, which was down 5853.66% from $0.12 recorded in Q2 2025.
- In the past 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) ranged from a high of $0.41 in Q3 2024 and a low of -$1.09 during Q3 2021
- In the last 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) had a median value of $0.06 in 2025 and averaged $0.03.
- Per our database at Business Quant, Puma Biotechnology's EPS (Weighted Average and Diluted) skyrocketed by 130000.0% in 2023 and then tumbled by 43333.33% in 2024.
- Over the past 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) (Quarter) stood at $0.1 in 2021, then plummeted by 224.77% to -$0.12 in 2022, then surged by 300.37% to $0.25 in 2023, then dropped by 0.37% to $0.25 in 2024, then tumbled by 31.75% to $0.17 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.17 in Q3 2025, compared to $0.12 in Q2 2025 and $0.06 in Q1 2025.